Ellipses Pharma and SunRock Biopharma enter into a licensing agreement for a first-in-class bifunctional...
Newsletter
Error at the newsletter cancelation
There is a mistake occured at the cancelation. Please try again.
Up to Date
Hamburg-based CRO Evotec SE has inked a drug development partnership with Spanish Almirall SA in dematology.
Avantium NV will get a €3m EU funding for a feasibility study of the electrochemical conversion of CO2 to...
Share
